Pimavanserin: A novel drug approved to treat Parkinson’s disease psychosis

Amanda K. Kitten, Sarah A. Hallowell, Stephen R Saklad, Kirk E. Evoy

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Pimavanserin: A novel drug approved to treat Parkinson’s disease psychosis'. Together they form a unique fingerprint.

Medicine & Life Sciences